Stochastic Process Model has many applications in analysis of longitudinal biodemographic data. In general, such data contain various physiological variables (sometimes known as covariates or physiological indices). Longitudinal data can also contain genetic information available for all or a part of participants. Taking advantage from both genetic and non-genetic information can provide future insights into a broad range of processes describing aging-related changes in the organism. In this work, we implemented a multi-dimensional Genetic Stochastic Process Model (GenSPM) in newly developed software tool, an Rpackage stpm (available from CRAN: https://cran.rproject.org/web/packages/stpm), which allows researchers performing such kind of analysis.
INTRODUCTION
Developing aging-related diseases is mediated by thousands of biological and physiological variables, which are undergo environmental and social factors, as well as individual behavioral patterns. Various studies show involvement of genetic component in developing aging-related diseases/changes and its potential effect on longevity [1] [2] [3] . Longitudinal study is probably the most important component of study and evaluating contribution of physiological variables to decline of the health/well-being status and a lifespan. Longitudinal data can also contain genetic information of individuals participated to the study. In such data genetic component represents genetic information in form of a genetic marker describing a particular allele.
The Stochastic Process Model (SPM) [4] , and its extension, a genetic SPM (GenSPM) [5] , developed to deal with longitudinal data with presence of genetic information, and represents an important step toward joint analysis of longitudinal data (with corresponding genetic information) by considering together genetic-and non-genetic groups (genotyped and non-genotyped groups of participants). In this work, we (i) further extend the conception of the GenSPM to a multi-dimensional case by performing simulations and testing on two physiological variables and (ii) provide a corresponding software tool: an R-package stpm that implements the GenSPM methodology.
METHODS
Genetic SPM (GenSPM), presented in 2009 by Arbeev at al [5] , extends the basic stochastic process model conception by introducing a categorical variable, Z, which may be a specific value of a genetic marker or, in general, any categorical variable. Currently, Z is presented in two gradations: 0 or 1 in a genetic group of interest, assuming that P(Z=1) = p, p ∈ [0, 1], were p is the proportion of carriers and non-carriers of an allele in a population. We also present a corresponding software tool, an Rpackage stpm, which is the first publicly available software, implementing the general SPM and its extension, the GenSPM, allowing researchers analyzing and making predictions from longitudinal data with genetic component.
Description of algorithms
The block-scheme of the GenSPM is presented in Figure 1 . In the specification of the basic SPM described in 2007 paper by Yashin and colleagues [4] the stochastic differential equation describing the age dynamics of a physiological variable (a dynamic component of the model) is: a(Z, t)(Y(t) -f 1 (Z, t))dt + b(Z, t)dW(t), Y(t = t 0 ) .
dY(t) =
Here in this equation, Y(t) is a k × 1 matrix, where k is a number of covariates, which is a model dimension) describing the value of a physiological variable at a time (e.g. age) t. f 1 (Z, t) is a k × 1 matrix that corresponds to the long-term average value of the stochastic process Y(t), which describes a trajectory of individual variable influenced by different factors represented by a random Wiener process W(t). The negative feedback coefficient a(Z, t) (k × k matrix) characterizes the rate at which the stochastic process goes to its mean. In research on aging and well-being, f 1 (Z, t) represents the average allostatic trajectory and a(t) in this case represents the adaptive capacity of the organism. Coefficient b(Z, t) (k × 1 matrix) characterizes a strength of the random disturbances from Wiener process W(t). All of these parameters depend on Z (a genetic marker having values 1 or 0).
The following function μ(t, Y(t)) represents a hazard rate:
In this equation: μ 0 (t) is the baseline hazard, which represents a risk when Y(t) follows its optimal trajectory; f(t) (k × 1 matrix) represents the optimal trajectory that minimizes the risk and Q(Z, t) (k x k matrix) represents a sensitivity of risk function to deviation from the norm. In general, model coefficients a(Z, t),
and μ 0 (t) are time(age)-dependent. For example, the coefficient a can be assumed as (i) -0.05 (a constant, time-independent, one-dimensional model) or (ii) a(t) = a 0 + b 0 t (time-dependent), in which a 0 and b 0 are unknown parameters to be estimated. Symbol '*' denotes transpose operation. In order to estimate coefficients a(Z, t), f 1 (Z, t), Q(Z, t), f(Z, t), b(Z, t) and μ 0 (t) which are the parameters of stochastic process, a method of maximizing likelihood is used (the actual likelihood equations are described in [5] ).
RESULTS AND DISCUSSION
We developed a first software implementation of a multidimensional genetic SPM, GenSPM by corresponding software tool: an R-package stpm, which was verified thought extensive simulation and validation studies. The package is freely available for download from CRAN: https://cran.rproject.org/web/packages/stpm.
Applying the Stochastic Process Model to analysis of longitudinal data uncovers influences of hidden components (adaptive capacity, allostatic load, resistance to stresses, physiological norm) of aging-related changes, which play important role in aging-related processes but cannot be measured directly with common statistical methods. In our approach we assume that the hazard rate (incidence rate related to changing physiological variable with age) has the form of U-or J-shape [6, 7] , which is biologically justified by empirical observations. In reality, the true form of such function is not known and since it is impossible to estimate the true form from the data, incorrectly assumed hazard may introduce additional bias. Additional investigations are needed in order to evaluate effects of different forms of hazard functions on results. Future work includes further improvements of the model, e.g. introducing three genetic markers and testing on higher number of variables
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